Mullighan CG - Search Results

1

Clinical significance of low levels of minimal residual disease at the end of remission induction therapy in childhood acute lymphoblastic leukemia.

Stow P, Key L, Chen X, Pan Q, Neale GA, Coustan-Smith E, Mullighan CG, Zhou Y, Pui CH, Campana D. Stow P, et al. Among authors: mullighan cg. Blood. 2010 Jun 10;115(23):4657-63. doi: 10.1182/blood-2009-11-253435. Epub 2010 Mar 19. Blood. 2010. PMID: 20304809 Free PMC article.

2

Genomic assessment of pediatric acute leukemia.

Mullighan CG, Flotho C, Downing JR. Mullighan CG, et al. Cancer J. 2005 Jul-Aug;11(4):268-82. doi: 10.1097/00130404-200507000-00003. Cancer J. 2005. PMID: 16197717 Review.

3

Tumor-specific genetic lesions and their influence on therapy in pediatric acute lymphoblastic leukemia.

Downing JR, Mullighan CG. Downing JR, et al. Among authors: mullighan cg. Hematology Am Soc Hematol Educ Program. 2006:118-22, 508. doi: 10.1182/asheducation-2006.1.118. Hematology Am Soc Hematol Educ Program. 2006. PMID: 17124049 Review.

4

Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia.

Mullighan CG, Goorha S, Radtke I, Miller CB, Coustan-Smith E, Dalton JD, Girtman K, Mathew S, Ma J, Pounds SB, Su X, Pui CH, Relling MV, Evans WE, Shurtleff SA, Downing JR. Mullighan CG, et al. Nature. 2007 Apr 12;446(7137):758-64. doi: 10.1038/nature05690. Nature. 2007. PMID: 17344859

5

BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros.

Mullighan CG, Miller CB, Radtke I, Phillips LA, Dalton J, Ma J, White D, Hughes TP, Le Beau MM, Pui CH, Relling MV, Shurtleff SA, Downing JR. Mullighan CG, et al. Nature. 2008 May 1;453(7191):110-4. doi: 10.1038/nature06866. Epub 2008 Apr 13. Nature. 2008. PMID: 18408710

6

Failure of CDKN2A/B (INK4A/B-ARF)-mediated tumor suppression and resistance to targeted therapy in acute lymphoblastic leukemia induced by BCR-ABL.

Mullighan CG, Williams RT, Downing JR, Sherr CJ. Mullighan CG, et al. Genes Dev. 2008 Jun 1;22(11):1411-5. doi: 10.1101/gad.1673908. Genes Dev. 2008. PMID: 18519632 Free PMC article.

7

JAK2--a new player in acute lymphoblastic leukaemia.

Mullighan CG. Mullighan CG. Lancet. 2008 Oct 25;372(9648):1448-50. doi: 10.1016/S0140-6736(08)61342-2. Epub 2008 Sep 19. Lancet. 2008. PMID: 18805580 No abstract available.

8

Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia.

Mullighan CG, Phillips LA, Su X, Ma J, Miller CB, Shurtleff SA, Downing JR. Mullighan CG, et al. Science. 2008 Nov 28;322(5906):1377-80. doi: 10.1126/science.1164266. Science. 2008. PMID: 19039135 Free PMC article.

9

Acquired variation outweighs inherited variation in whole genome analysis of methotrexate polyglutamate accumulation in leukemia.

French D, Yang W, Cheng C, Raimondi SC, Mullighan CG, Downing JR, Evans WE, Pui CH, Relling MV. French D, et al. Among authors: mullighan cg. Blood. 2009 May 7;113(19):4512-20. doi: 10.1182/blood-2008-07-172106. Epub 2008 Dec 9. Blood. 2009. PMID: 19066393 Free PMC article.

10

Global genomic characterization of acute lymphoblastic leukemia.

Mullighan CG, Downing JR. Mullighan CG, et al. Semin Hematol. 2009 Jan;46(1):3-15. doi: 10.1053/j.seminhematol.2008.09.005. Semin Hematol. 2009. PMID: 19100363 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

386 results

Search Page

Filters